Nature· Michael Eisenstein·· 14 hours agoScore25
Editor’s pick: Bioptimus
In brief
Bioptimus is featured in Nature Biotechnology's annual editor's pick. The company is developing multimodal, multiscale AI pathology models for biomarker identification and drug treatment prediction. Each year the journal highlights companies that received sizeable early-stage funding in the previous year.
Source: Nature